Aspe et al. [163] previously inoculated engineered exosomes loaded with Survivin-T34A, which blocks survivin, into pancreatic adenocarcinoma cell lines and treated pancreatic cancer cells in combination with gemcitabine. Here, BIRC5 is linked to pancreatic adenocarcinoma.